ARC
ELGX

Absolute Return Capital’s Endologix Inc ELGX Stock Holding History

Absolute Return Capital’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-692
Closed -$89K – 1462
2014
Q1 		$89K Buy
+692
New +$108K ﹤0.01% 1153

Other funds holding ELGX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Absolute Return Capital's ELGX Position: Q2 2014 in Review

Absolute Return Capital sold out of Endologix Inc (ELGX) in Q2 2014, closing a stake of 692 shares — an estimated $89K sold.

Absolute Return Capital first reported a position in ELGX in Q1 2014 and held it in 1 quarter. The position peaked at $89K in Q1 2014. 119 funds tracked by Wall St. Rank hold ELGX as of Q2 2014.

  • Absolute Return Capital reported no remaining Endologix Inc position as of Q2 2014 after selling out during the quarter.
  • Absolute Return Capital sold 692 Endologix Inc shares in Q2 2014, an estimated $89K.
  • Absolute Return Capital first reported a position in Endologix Inc in Q1 2014 and held it in 1 quarter.
  • Absolute Return Capital's Endologix Inc position peaked at $89K in Q1 2014.
  • 119 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2014.

Based on Absolute Return Capital's 13F filing for Q2 2014, filed 14 Aug 2014.